Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013.

Remes K, Anttila P, Silvennoinen R, Putkonen M, Ollikainen H, Terävä V, Sinisalo M, Kananen K, Schain F, Castren-Kortegangas P, Järvinen TM, Pisini M, Wahl F, Dixon T, Leval A.

PLoS One. 2018 Dec 5;13(12):e0208507. doi: 10.1371/journal.pone.0208507. eCollection 2018.

2.

Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.

Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Säily M, Sankelo M, Putkonen M, Partanen A, Pyörälä M, Savolainen ER, Mäntymaa P, Pelkonen J, Jantunen E, Varmavuo V.

Leuk Lymphoma. 2019 Feb;60(2):453-461. doi: 10.1080/10428194.2018.1485911. Epub 2018 Aug 30.

PMID:
30160591
3.

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing.

Majumder MM, Silvennoinen R, Anttila P, Tamborero D, Eldfors S, Yadav B, Karjalainen R, Kuusanmäki H, Lievonen J, Parsons A, Suvela M, Jantunen E, Porkka K, Heckman CA.

Oncotarget. 2017 May 5;8(34):56338-56350. doi: 10.18632/oncotarget.17630. eCollection 2017 Aug 22.

4.

Impact of lenalidomide-based induction therapy on the mobilization of CD34+ cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.

Partanen A, Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Putkonen M, Sankelo M, Pelkonen J, Mäntymaa P, Varmavuo V, Jantunen E.

Transfusion. 2017 Oct;57(10):2366-2372. doi: 10.1111/trf.14220. Epub 2017 Jul 5.

PMID:
28681435
5.

Attitudes and actions: A survey to assess statin use among Finnish patients with increased risk for cardiovascular events.

Silvennoinen R, Turunen JH, Kovanen PT, Syvänne M, Tikkanen MJ.

J Clin Lipidol. 2017 Mar - Apr;11(2):485-494. doi: 10.1016/j.jacl.2017.02.013. Epub 2017 Mar 9.

PMID:
28502506
6.

Phytosterol-mediated inhibition of intestinal cholesterol absorption in mice is independent of liver X receptor.

Cedó L, Santos D, Ludwig IA, Silvennoinen R, García-León A, Kaipiainen L, Carbó JM, Valledor AF, Gylling H, Motilva MJ, Kovanen PT, Lee-Rueckert M, Blanco-Vaca F, Escolà-Gil JC.

Mol Nutr Food Res. 2017 Sep;61(9). doi: 10.1002/mnfr.201700055. Epub 2017 Apr 5.

PMID:
28296229
7.

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

Varmavuo V, Silvennoinen R, Anttila P, Säily M, Sankelo M, Putkonen M, Ahonen J, Mahlamäki E, Mäntymaa P, Savolainen ER, Remes K, Jantunen E.

Ann Hematol. 2016 Oct;95(10):1653-9. doi: 10.1007/s00277-016-2772-1. Epub 2016 Aug 3.

PMID:
27485453
8.

Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.

Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Säily M, Sankelo M, Terävä V, Putkonen M, Kuittinen T, Pelkonen J, Mäntymaa P, Remes K, Varmavuo V, Jantunen E.

Transfusion. 2016 Jun;56(6):1394-401. doi: 10.1111/trf.13574. Epub 2016 Apr 4.

PMID:
27041692
9.

USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.

Laurila PP, Soronen J, Kooijman S, Forsström S, Boon MR, Surakka I, Kaiharju E, Coomans CP, Van Den Berg SA, Autio A, Sarin AP, Kettunen J, Tikkanen E, Manninen T, Metso J, Silvennoinen R, Merikanto K, Ruuth M, Perttilä J, Mäkelä A, Isomi A, Tuomainen AM, Tikka A, Ramadan UA, Seppälä I, Lehtimäki T, Eriksson J, Havulinna A, Jula A, Karhunen PJ, Salomaa V, Perola M, Ehnholm C, Lee-Rueckert M, Van Eck M, Roivainen A, Taskinen MR, Peltonen L, Mervaala E, Jalanko A, Hohtola E, Olkkonen VM, Ripatti S, Kovanen PT, Rensen PC, Suomalainen A, Jauhiainen M.

Sci Transl Med. 2016 Jan 27;8(323):323ra13. doi: 10.1126/scitranslmed.aad0015.

PMID:
26819196
10.

Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland.

Lindström V, Aittoniemi J, Lyytikäinen O, Klemets P, Ollgren J, Silvennoinen R, Nuorti JP, Sinisalo M.

Infect Dis (Lond). 2016;48(5):399-402. doi: 10.3109/23744235.2015.1115894. Epub 2015 Dec 4.

PMID:
26635103
11.

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

Silvennoinen R, Anttila P, Säily M, Lundan T, Heiskanen J, Siitonen TM, Kakko S, Putkonen M, Ollikainen H, Terävä V, Kutila A, Launonen K, Räsänen A, Sikiö A, Suominen M, Bazia P, Kananen K, Selander T, Kuittinen T, Remes K, Jantunen E.

Bone Marrow Transplant. 2016 Mar;51(3):372-6. doi: 10.1038/bmt.2015.236. Epub 2015 Oct 5.

12.

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.

Valtola J, Varmavuo V, Ropponen A, Nihtinen A, Partanen A, Vasala K, Lehtonen P, Penttilä K, Pyörälä M, Kuittinen T, Silvennoinen R, Nousiainen T, Pelkonen J, Mäntymaa P, Jantunen E.

Transfusion. 2015 Oct;55(10):2358-68. doi: 10.1111/trf.13170. Epub 2015 May 28.

PMID:
26018461
13.

Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice.

Silvennoinen R, Quesada H, Kareinen I, Julve J, Kaipiainen L, Gylling H, Blanco-Vaca F, Escola-Gil JC, Kovanen PT, Lee-Rueckert M.

Physiol Rep. 2015 May 11;3(5). pii: e12402. doi: 10.14814/phy2.12402.

14.

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

Grövdal M, Nahi H, Gahrton G, Liwing J, Waage A, Abildgaard N, Pedersen PT, Hammerstrøm J, Laaksonen A, Bazia P, Terava V, Ollikainen H, Silvennoinen R, Putkonen M, Anttila P, Porkka K, Remes K.

Bone Marrow Transplant. 2015 Jun;50(6):808-12. doi: 10.1038/bmt.2015.39. Epub 2015 Apr 13.

PMID:
25867654
15.

Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.

Kareinen I, Cedó L, Silvennoinen R, Laurila PP, Jauhiainen M, Julve J, Blanco-Vaca F, Escola-Gil JC, Kovanen PT, Lee-Rueckert M.

J Lipid Res. 2015 Feb;56(2):241-53. doi: 10.1194/jlr.M050948. Epub 2014 Dec 3.

16.

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Silvennoinen R, Lundan T, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Huotari V, Mäntymaa P, Siitonen S, Uotila L, Penttilä TL, Juvonen V, Selander T, Remes K.

Blood Cancer J. 2014 Oct 10;4:e250. doi: 10.1038/bcj.2014.69.

17.

Cat scratch disease caused by Bartonella grahamii in an immunocompromised patient.

Oksi J, Rantala S, Kilpinen S, Silvennoinen R, Vornanen M, Veikkolainen V, Eerola E, Pulliainen AT.

J Clin Microbiol. 2013 Aug;51(8):2781-4. doi: 10.1128/JCM.00910-13. Epub 2013 Jun 5.

18.

Optical evaluation of ink prints made with heat-treated alder and birch.

Penttinen N, Laitinen K, Silvennoinen R, Tolonen Y, Moilanen T.

Appl Opt. 2012 Dec 20;51(36):8808-16. doi: 10.1364/AO.51.008808.

PMID:
23262620
19.

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.

Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Säily M, Sikiö A, Opas J, Penttilä K, Kuittinen T, Honkanen T, Lundán T, Juvonen V, Luukkaala T, Remes K.

Br J Haematol. 2013 Feb;160(4):561-4. doi: 10.1111/bjh.12139. Epub 2012 Dec 4. No abstract available.

PMID:
23206270
20.

Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.

Escolà-Gil JC, Julve J, Llaverias G, Urpi-Sarda M, Silvennoinen R, Lee-Rueckert M, Andres-Lacueva C, Blanco-Vaca F.

Transl Res. 2013 Feb;161(2):110-7. doi: 10.1016/j.trsl.2012.10.008. Epub 2012 Nov 10.

PMID:
23146569
21.

Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption.

Silvennoinen R, Escola-Gil JC, Julve J, Rotllan N, Llaverias G, Metso J, Valledor AF, He J, Yu L, Jauhiainen M, Blanco-Vaca F, Kovanen PT, Lee-Rueckert M.

Circ Res. 2012 Nov 9;111(11):1459-69. doi: 10.1161/CIRCRESAHA.112.277962. Epub 2012 Aug 28.

PMID:
22931956
22.

CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients.

Varmavuo V, Mäntymaa P, Silvennoinen R, Nousiainen T, Kuittinen T, Jantunen E.

Transfusion. 2013 May;53(5):1024-32. doi: 10.1111/j.1537-2995.2012.03848.x. Epub 2012 Aug 15.

PMID:
22897584
23.

Optical analysis of adsorption sensitivity of titanium, Ti-6Al-4V, and Ti-35Nb-6Ta.

Penttinen N, Hasoň S, Vaněk J, Silvennoinen R.

Appl Opt. 2012 Apr 1;51(10):C32-7. doi: 10.1364/AO.51.000C32.

PMID:
22505108
24.

High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy.

Sinisalo M, Silvennoinen R, Wirta O.

Am J Hematol. 2012 Jun;87(6):640. doi: 10.1002/ajh.23189. Epub 2012 Mar 31.

25.

Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse.

Lee-Rueckert M, Silvennoinen R, Rotllan N, Judström I, Blanco-Vaca F, Metso J, Jauhiainen M, Kovanen PT, Escola-Gil JC.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):520-7. doi: 10.1161/ATVBAHA.110.221069. Epub 2011 Jan 6.

PMID:
21212401
26.

Diffractive-optics-based sensor as a tool for detection of biocompatibility of titanium and titanium-doped hydrocarbon samples.

Silvennoinen R, Hasoň S, Vetterl V, Penttinen N, Silvennoinen M, Myller K, Cernochová P, Bartáková S, Prachár P, Cvrček L.

Appl Opt. 2010 Oct 10;49(29):5583-91. doi: 10.1364/AO.49.005583.

PMID:
20935705
27.

Analysis of the willow root system by electrical impedance spectroscopy.

Cao Y, Repo T, Silvennoinen R, Lehto T, Pelkonen P.

J Exp Bot. 2011 Jan;62(1):351-8. doi: 10.1093/jxb/erq276. Epub 2010 Aug 26.

28.

Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.

Syrjälä H, Ohtonen P, Kinnunen U, Räty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itälä-Remes M, Silvennoinen R, Koistinen P; Finnish Leukemia Group.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1211-8. doi: 10.1007/s10096-010-0984-1. Epub 2010 Jun 17.

PMID:
20556469
29.

An appraisal of the electrical resistance method for assessing root surface area.

Cao Y, Repo T, Silvennoinen R, Lehto T, Pelkonen P.

J Exp Bot. 2010 May;61(9):2491-7. doi: 10.1093/jxb/erq078. Epub 2010 Apr 2.

30.

Sensing of human plasma fibrinogen on polished, chemically etched and carbon treated titanium surfaces by diffractive optical element based sensor.

Silvennoinen R, Vetterl V, Hason S, Tuononen H, Silvennoinen M, Myller K, Cvrcek L, Vanek J, Prachar P.

Opt Express. 2008 Jul 7;16(14):10130-40.

PMID:
18607420
31.

Acute lymphoblastic leukemia in adolescents and young adults in Finland.

Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM.

Haematologica. 2008 Aug;93(8):1161-8. doi: 10.3324/haematol.12466. Epub 2008 Jun 12.

32.

Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.

Jantunen E, Itälä M, Siitonen T, Kuittinen T, Heiskanen J, Koivunen E, Juvonen E, Silvennoinen R, Nousiainen T, Koistinen P, Volin L, Remes K.

Bone Marrow Transplant. 2008 Feb;41(3):239-44. Epub 2007 Oct 29.

PMID:
17968327
33.

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.

Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E; Finnish Leukaemia Group.

Eur J Haematol. 2007 Jun;78(6):477-86. Epub 2007 Mar 28.

PMID:
17391337
34.

Reflectance study of compressed paper.

Oksman A, Silvennoinen R, Peiponen KE, Avikainen M, Komulainen H.

Appl Spectrosc. 2004 Apr;58(4):481-5.

PMID:
17140497
35.

Local and average gloss from flat-faced sodium chloride tablets.

Juuti M, van Veen B, Peiponen KE, Ketolainen J, Kalima V, Silvennoinen R, Pakkanen TT.

AAPS PharmSciTech. 2006 Jan 13;7(1):E7.

36.

Local and average gloss from flat-faced sodium chloride tablets.

Juuti M, van Veen B, Peiponen KE, Ketolainen J, Kalima V, Silvennoinen R, Pakkanen TT.

AAPS PharmSciTech. 2006 Mar;7(1):E43-E48. doi: 10.1208/pt070107. Epub 2017 Mar 8.

37.

Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.

Ruutu T, Koivunen E, Nousiainen T, Pelliniemi TT, Almqvist A, Anttila P, Jantunen E, Koistinen P, Koponen A, Mikkola M, Oksanen K, Pulli T, Remes K, Sarkkinen R, Silvennoinen R, Timonen T, Vanhatalo S, Elonen E; Finnish Leukaemia Group.

Eur J Haematol. 2004 Jan;72(1):38-44.

PMID:
14962261
38.

Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses.

Silvennoinen R, Malminiemi K, Malminiemi O, Seppälä E, Vilpo J.

Pharmacol Toxicol. 2000 Nov;87(5):223-8.

PMID:
11129502
39.

Dynamic laser speckle pattern in monitoring of local deformation of tablet surface after compression.

Silvennoinen R, Hyvärinen V, Raatikainen P, Peiponen K.

Int J Pharm. 2000 Apr 20;199(2):205-8.

PMID:
10802414
40.

Diffractive optical element based sensor for surface quality inspection of concave punches.

Hyvärinen V, Silvennoinen R, Peiponen K, Niskanen T.

Eur J Pharm Biopharm. 2000 Mar;49(2):167-9.

PMID:
10704900
41.

Optical inspection of punches: flat surfaces.

Hyvärinen V, Peiponen K, Silvennoinen R, Raatikainen P, Paronen P, Niskanen T.

Eur J Pharm Biopharm. 2000 Jan;49(1):87-90.

PMID:
10613932
42.

Optical surface roughness study of starch acetate compacts.

Silvennoinen R, Peiponen KE, Hyvärinen V, Raatikainen P, Paronen P.

Int J Pharm. 1999 May 25;182(2):213-20.

PMID:
10341310
43.
44.

Characterization of Fresnel holograms by a pixel phase-error function.

Silvennoinen R, Räsänen J, Honkanen M.

Opt Lett. 1996 Apr 1;21(7):513-5.

PMID:
19865456
45.

Temporal, Spatial, and Environmental classification of Pine Reflectance Spectra.

Silvennoinen R, Jaaskelainen T, Nygren K, Hiltunen J, Parkkinen J.

Environ Sci Technol. 1995 Jun 1;29(6):1456-9. doi: 10.1021/es00006a005. No abstract available.

PMID:
22276864
46.

Classification of the reflectance spectra of pine, spruce, and birch.

Jaaskelainen T, Silvennoinen R, Hiltunen J, Parkkinen JP.

Appl Opt. 1994 Apr 20;33(12):2356-62. doi: 10.1364/AO.33.002356.

PMID:
20885586
47.

Two-wave mixing in photorefractive Bi(12)SiO(20) fibers.

Kamshilin AA, Silvennoinen R, Jaaskelainen T, Lima CJ, Andreeta MR, Prokofiev VV.

Opt Lett. 1993 May 1;18(9):690-2.

PMID:
19802241
48.

[Constipation after delivery: double-blind comparative study of 2 laxative preparations].

Raatikainen R, Silvennoinen R.

Katilolehti. 1974 Nov;79(11):421-2. Finnish. No abstract available.

PMID:
4498871

Supplemental Content

Loading ...
Support Center